Delivery Order SPE2DB20D3111-SPE2DB24FA8ZF

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The order is for the pharmaceutical product Rifampin 300 mg capsules and has a firm fixed price of $1,088.57. The contract has an ultimate completion date of July 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to federal agencies, including the DLA. The company holds several Indefinite Delivery Contracts...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg rifampin capsules. The $2,321.04 firm fixed price contract has an ultimate completion date of August 13, 2024. This order is not associated with a set-aside program. AmerisourceBergen, through its extensive pharmaceutical supply chain network, will provide these critical prescription medications to support military treatment...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $1,351.97 firm-fixed-price delivery order is for the supply of Rifampin 150 mg capsules. The contract has a period of performance through September 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and other federal agencies, valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,298.19, is for the delivery of 60 capsules of 300 mg Rifampin, a medication used to treat various bacterial infections. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $18,739.89 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of Rifampin 300 mg capsules, with a period of performance through July 26, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of essential...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,883.16 firm fixed-price contract is for the supply of 60 capsules of the drug Rifampin 300 mg. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation. The contract, valued at up to $2,070.28, is for the delivery of 60 capsules of Rifampin 300 mg, a prescription medication. The contract has a firm fixed price and an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,413.58 Firm Fixed Price delivery order is for 60 capsules of 300 mg Rifampin, a medication used to treat infections. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 capsules of 300 mg Rifampin, an antibiotic medication, with a ceiling value of $10,237.44. The contract is a firm fixed-price delivery order with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.36 firm fixed-price delivery order is for the supply of 60 count bottles of 300 mg Rifampin capsules. The award falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA8ZF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,046.98 firm fixed price contract is for the delivery of 60 capsules of 300 mg rifampin, a prescription medication. The order has an ultimate completion date of September 5, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for providing a wide range of medical commodities and prescription drugs to support federal healthcare programs. This contract award is not associated with any set-aside designation.

Generated 12/4/24, 10:09 AM